BST: Target Met, Moving From Sell To Hold (NYSE:BST)
seekingalpha.com
news
2022-10-17 13:08:51

djmilic Thesis We recently started covering the BlackRock Science and Technology Trust (NYSE:BST), and upon our review we assigned it a Sell rating. It is important to keep in mind that holdings in a CEF do not necessarily need to be toxic for them to lose value, they just need to be overpriced. Starting valuation levels are extremely important in today's environment where short dated treasury yields are at 4% and very likely heading to 5%. The moniker TINA is gone, and TARA is now in vogue. Our initial article asserted that the fund was overvalued from both an intrinsic perspective (i.
